People: Eris Lifesciences Ltd (ERIS.NS)
Mr. Prashant Gupta serves as Additional Independent Director of the Company. Mr. Prashant Gupta is a Partner in the firm’s corporate department, focusing primarily on capital markets transactions. He represents both issuers and underwriters in various equity and debt capital raising transactions, including initial public offerings, rights issues and QIP offerings, buy-backs, capital restructurings and pre-IPO private placements. Prashant has been recognized by Who’s Who Legal, Chambers Asia, Indian Lawyer 250, Legal500 and other legal industry publications as one of the leading capital markets practitioners in India. He has also been selected by the Indian Business Law Journal as one of the top 100 lawyers in India in 2016 and 2017. Prashant has advised on capital markets transactions that have raised over US$30 billion globally. Several of the deals, as well as other transactions he has advised on, have been selected as ‘Deals of the Year’ by the International Financial Law Review (IFLR) Asia, India Business Law Journal, and the Asian-MENA Counsel Magazine. He has also acted on various international capital markets transactions by India focused companies, including the IPOs in the United States (NASDAQ/NYSE) by MakeMyTrip Limited, Azure Power Global Limited, Eros International plc, and Videocon d2h, as well as the reorganization and listing on the NYSE by Vedanta Limited. He has also advised on the buyback of shares by Infosys Limited, which was amongst the largest buybacks in India. He has advised the underwriters in the US$3.4 billion IPO by Coal India Limited in 2010, which has been the largest IPO in India and acted as sole Indian counsel for the US$1.7 billion bond offering by Vedanta Resources, which has been the largest bond offering by an Indian group. Prashant received his Bachelor of Arts in Jurisprudence and Master of Arts in Jurisprudence from the University of Oxford, England, and a Bachelor of Commerce from the Shri Ram College of Commerce, University of Delhi.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|